What Happens After a GLP-1 Plateau

Your body defends its set point. When intake drops, signaling adjusts, energy use adjusts, and the change that was working starts working less. This happens to nearly everyone eventually and it happens regardless of effort.

Before anyone talks about a procedure, the basics deserve a look.

Correcting any item below sometimes restarts progress without any further intervention.

• Has the dose been optimized, or did escalation stop early because of side effects?
• Has adherence been consistent?
• Were there gaps in supply or coverage?
• Is protein intake steady and adequate?
• Is sleep adequate?
• Is sleep apnea being treated?
• Are other medications working against the plan?

If your health markers improved, maintaining that is a real outcome even if the number stops moving. Blood pressure, blood sugar, and liver health matter more than the scale.

In this case the plan becomes maintenance and monitoring, with nutrition support to protect muscle.

Weight regain is common after anti-obesity medication is discontinued, although the amount and timing vary by medication and individual. GLP-1 therapy and endoscopic or surgical treatment are increasingly combined rather than treated as alternatives, and for someone who has plateaued or discontinued, ESG can provide an anatomic complement.

Endoscopic sleeve gastroplasty is done through a scope with no incisions and no tissue removed. ESG and sleeve gastrectomy differ in invasiveness, expected weight loss, risks, reversibility, and follow-up needs. Which one fits depends on your health, not on a rule.

Sometimes the answer is a different medication, a different combination, or a referral for a condition that has not been fully addressed. That is a legitimate outcome of an evaluation and we will say so if that is what we find.

This page is educational. It is not medical advice and it does not replace an evaluation. What is right for you depends on your history, your testing, and a conversation with a surgeon.